Regulatory Nebilet PMS

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of Nebivolol administered in Korean patients according to the prescribing information

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Nebivolol

Criteria

All subjects must satisfy the following criteria at PMS entry according to KFDA PMS regulation:

• Subjects with indication in the prescribing information

• Subjects administrated Nebivolol by physician's decision

• Subjects with no contraindication according to the prescribing information